Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study)

被引：0
|
作者：
Chi, Heng [1 ]
Xie, Qing [2 ]
Zhang, Ning-Ping [3 ]
Qi, Xun [4 ]
Liang, Chen [4 ]
Guo, Simin [2 ]
Guo, Qing [2 ]
Arends, Pauline [1 ]
Wang, Jiyao [3 ]
Verhey, Elke [1 ]
de Knegt, Robert J. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ,5 ]
机构：
[1] Erasmus MC Univ Med Ctr Rotterdam, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Hepatitis Dis, Shanghai 200433, Peoples R China
[5] Univ Toronto, Toronto Gen & Western Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2002
引用
收藏
页码：1183A / 1183A
页数：1
相关论文
共 50 条
  • [21] Higher relapse and retreatment rates in patients who started as HBeAg positive than negative after stopping long-term nucleos(t) ide analogue therapy: results from the randomized controlled STOP study
    Liem, Seng
    Fung, Scott
    Wong, David
    Yim, Colina
    Chen, Jenny
    Noureldin, Seham
    Feld, Jordan
    Hansen, Bettina
    Janssen, Harry
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E34 - E34
  • [22] Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
    van Boemmel, Florian
    Stein, Kerstin
    Heyne, Renate
    Moeller, Hjoerdis
    Petersen, Joerg
    Buggisch, Peter
    Berg, Christoph
    Werner, Christoph
    Zeuzem, Stefan
    Herrmann, Andreas
    Reuken, Philipp
    Sprinzl, Martin
    Grambihler, Annette
    Schott, Eckart
    Benckert, Julia
    Pathil, Anita
    von Arnim, Ulrike
    Keitel, Verena
    Trauth, Janina
    Georg, Simon Karl
    Trautwein, Christian
    Trein, Andreas
    Hueppe, Dietrich
    Cornberg, Markus
    Lammert, Frank
    Ingiliz, Patrick
    Zachoval, Reinhart
    Hinrichsen, Holger
    Zipprich, Alexander
    Klinker, Hartwig
    Zur Wiesch, Julian Schulze
    Brosteanu, Oana
    Schmiedeknecht, Anett
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2020, 73 : S118 - S119
  • [23] STRONGER HBV DNA SUPPRESSION IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B ACHIEVING HBEAG CLEARANCE DURING PEGINTERFERON ALFA-2B THERAPY COMPARED WITH PLACEBO
    Hansen, Bettina E.
    Rijckborst, Vincent
    ter Borg, Martijn J.
    Janssen, Harry L.
    HEPATOLOGY, 2010, 52 (04) : 563A - 563A
  • [24] ADDING PEGINTERFERON alfa-2a ON NUCLEOS(T)IDE ANALOGUES THERAPY IMPROVES HBeAg SEROCONVERSION AND qHBsAg DECLINE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS WHO HAVE ACHIEVED VIROLOGICAL RESPONSES
    Li, Q.
    Dong, G.
    Yu, J.
    Sun, C.
    Xie, S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S307 - S308
  • [25] Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up
    van Campenhout, Margo J. H.
    Brouwer, Willem Pieter
    Xie, Qing
    Guo, S.
    Chi, Heng
    Qi, Xun
    Tabak, Fehmi
    Streinu-Cercel, Adrian
    Wang, Ji-Yao
    Zhang, Ning-Ping
    Idilman, Ramazan
    Reesink, Hendrik W.
    Diculescu, Mircea
    Simon, Krzysztof
    Akdogan, Meral
    Mazur, Wlodzimierz
    de Knegt, Rob J.
    Verhey, Elke
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 109 - 117
  • [26] SERUM HBSAG LEVELS DURING PEGINTERFERON ALFA-2A TREATMENT IN HBEAG-POSITIVE CHRONIC HEPATITIS B: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
    Kim, Bo Hyun
    Kim, Won
    Song, Fun Young
    Park, Myoung Hee
    Yoon, Jung-Hwan
    Lee, Youn Jae
    Park, Sung Jae
    Jung, Eun Uk
    Kim, Donghee
    Kim, Yoon Jun
    Lee, Hyo-Suk
    HEPATOLOGY, 2010, 52 (04) : 514A - 514A
  • [27] Histological responses of peginterferon alpha add-on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long-term nucleos(t)ide analog treatment
    Li, Guojun
    Zhang, Qiran
    Yu, Yiqi
    Qiu, Chao
    Zhang, Hanyue
    Zhang, Miaoqu
    Song, Zhangzhang
    Yang, Yusheng
    Hong, Jiemin
    Lu, Jian
    Li, Niuniu
    Tang, Quanzhen
    Xu, Long
    Wang, Xuanyi
    Zhang, Wenhong
    Chen, Zhi
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 50 - 58
  • [28] Sustained Responses in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue Drug-resistance after Peg-interferon Alfa-2a Add-on Treatment: A Long-term Cohort Study
    Liu, Yunhua
    Li, Weikun
    Jia, Ting
    Peng, Dan
    Li, Huimin
    Li, Xiaofei
    Lv, Songqin
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) : 18 - 24
  • [29] HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis
    Xing, Tongjing
    Xu, Hongtao
    Cao, Lin
    Ye, Maocong
    PLOS ONE, 2017, 12 (01):
  • [30] Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg- positive Patients with High Serum Fucosyl- Agalactosyl IgG
    Ho, Cheng-Hsun
    Tsai, Hung-Wen
    Lee, Chen-Yeh
    Huang, Li-Juan
    Chien, Rong-Nan
    Wu, I-Chin
    Chiu, Yen-Cheng
    Liu, Wen-Chun
    Cheng, Pin-Nan
    Chang, Ting-Tsung
    Chen, Shu-Hui
    SCIENTIFIC REPORTS, 2017, 7
12345